Open
  
      Actively Recruiting
  
  Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients
About
Brief Summary
              
A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced hypothermia for neuroprotection in comatose survivors of cardiac arrest.
      Primary Purpose
    
          
      Study Type
    
          
      Phase
    
      Eligibility
      Gender
    
      
      Healthy Volunteers
    
      
      Minimum Age
    
      
      Maximum Age
    
      Inclusion Criteria:
- Coma after resuscitation from out of hospital cardiac arrest
 - Cooled to <34 deg C with 240 minutes of cardiac arrest
 - Definitive temperature control applied
 - Age ≥ 18 years
 - Informed consent from legal authorized representative (LAR) including intent to maintain life support for 96 hours
 - Enrollment within 6 hours of initiation of cooling
 
Exclusion Criteria:
- Hemodynamic instability
 - Pre-existing neurological disability or condition that confounds outcome determination
 - Pre-existing terminal illness, unlikely to survive to outcome determination
 - Planned early withdrawal of life support
 - Presumed sepsis as etiology of arrest
 - Prisoner
 
Join this Trial
      Contact our clinical trial navigators for opportunities that may be suitable for you
    
  
      Study Stats
    
          
      Protocol No.
    
      20-001122
      
  
      Category
    
      Heart/Cardiovascular Diseases
      
          Principal Investigator
        
        
          
      Contact
    
      
        Location
      
      - UCLA Westwood